Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

International Business Machines Corp IBM.30A


Primary Symbol: IBM Alternate Symbol(s):  N.IBM

International Business Machines Corporation is engaged in addressing the hybrid cloud and artificial intelligence (AI) opportunity with a platform-centric approach, focused on providing client value through a combination of technology and business expertise. Its segments include Software, Consulting, Infrastructure and Financing. Its Software segment comprises two business areas: Hybrid Platform & Solutions, which includes software to help clients operate, manage and optimize their IT resources and business processes within hybrid, multi-cloud environments, and transaction processing, which includes software that supports client’s mission-critical, on-premises workloads in industries such as banking, airlines and retail. Consulting segment is engaged in business transformation, technology consulting and application operations. Infrastructure segment is engaged in hybrid infrastructure and infrastructure support. Financing segment is engaged in client financing and commercial financing.


NYSE:IBM - Post by User

Post by jonathanSon Sep 21, 2022 7:09am
284 Views
Post# 34975698

steady revenue growth

steady revenue growth
including revenue from its hybrid cloud platform, Red Hat software, consulting services, and product sales to Kyndryl.
 
In its first quarter ended March 31, IBM reported revenue of $14.20 billion, up nearly 8 percent year over year. Net income, however, declined more than 23 percent to $733 million.
 
In January IBM struck a deal to sell its health-care data and analytics assets, including Health Insights, MarketScan and Micromedex, to global investment firm Francisco Partners
<< Previous
Bullboard Posts
Next >>